Navigation Links
Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
Date:3/9/2009

8 for non-inferiority).
  • Patients receiving 900-mcg albinterferon alfa-2b had comparable rates of serious and/or severe adverse events, vs. peginterferon alfa-2a, with 24.0% (106/442) in the albinterferon alfa-2b 900-mcg treatment group, vs. 23.1% (102/441) in the peginterferon alfa-2a treatment group.
  • Serious and/or severe pulmonary adverse events were infrequent and included the following: The rate of serious and/or severe pulmonary infections was comparable between the two groups, with 1.8% (8/442) for 900-mcg albinterferon alfa-2b, vs. 1.1% (5/441) for peginterferon alfa-2a; the rate of serious and/or severe respiratory, thoracic or mediastinal disorders was 2.5% (11/442) for 900-mcg albinterferon alfa-2b, vs. 0.5% (2/441) for peginterferon alfa-2a. Of the 11 disorders reported for 900-mcg albinterferon alfa-2b, three were classified as serious, and all three resolved off treatment.
  • Overall, adverse events observed were those typically associated with interferon therapy. The rate of discontinuations due to adverse events was 10.4% (46/442) for 900-mcg albinterferon alfa-2b, vs. 4.1% (18/441) for peginterferon alfa-2a.
  • Treatment Group Originally Randomized to Receive Albinterferon Alfa-2b 1200-mcg Every Two Weeks and Reduced to 900-mcg Following January 2008 Dose Modification, vs. Treatment Group Receiving Peginterferon Alfa-2a 180-mcg Every Week

    Due to the dose modification announced in January 2008, patients in the treatment group originally randomized to receive albinterferon alfa-2b 1200-mcg every two weeks had their dose modified to 900-mcg albinterferon alfa-2b every two weeks. Data from all three treatment groups in the ACHIEVE 1 study were analyzed according to the original dose assignment. The following results for the treatment group originally randomized to receive 1200-mcg albinterferon alfa-2b every two weeks did not impact the
    '/>"/>

    SOURCE Human Genome Sciences, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Drug Development Program Started Based on CAP(R) Human Cell Line
    2. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
    3. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
    4. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
    5. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
    6. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
    7. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
    8. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
    9. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
    10. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
    11. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/1/2015)... May 1, 2015   Heska Corporation (NASDAQ: ... a provider of advanced veterinary diagnostic and other specialty ... Executive Chair, will present at the 16th Annual B. Riley ... 13, 2015. The conference will be held May 12-14, 2015 ... Heska management will be available during the day on ...
    (Date:5/1/2015)... , May 1, 2015 At the ... 2-6 in Washington D.C. , Elekta ... solution that enables clinicians to leverage the enormous amount ... radiosurgery treatments conducted each year – to advance clinical ... Knife Registry is a cloud-based solution that allows practitioners ...
    (Date:5/1/2015)... 1, 2015 Braeburn Pharmaceuticals announced ... therapeutic focus beyond addiction and pain to ... Braeburn has acquired an implantable, six-month formulation ... for treatment of schizophrenia from Endo Pharmaceuticals. ... rights to other potential applications of the ...
    Breaking Medicine Technology:Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4
    ... SAN DIEGO, Oct. 28 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... 30, 2009. For the third quarter of 2009, the Company reported ... with a net loss of $17.7 million, or $0.46 per share, ... September 30, 2009, the Company reported a net loss of $43.1 ...
    ... BATESVILLE, Ind., Oct. 28 Hill-Rom Holdings, Inc. (NYSE: ... and 2010 financial guidance on Wednesday, November 11, 2009. ... morning on Thursday, November 12, 2009 at 7:30 a.m. EST. ... Quarter Earnings and 2010 Financial Guidance release will be issued ...
    Cached Medicine Technology:Neurocrine Biosciences Reports Third Quarter 2009 Results 2Neurocrine Biosciences Reports Third Quarter 2009 Results 3Neurocrine Biosciences Reports Third Quarter 2009 Results 4Neurocrine Biosciences Reports Third Quarter 2009 Results 5Neurocrine Biosciences Reports Third Quarter 2009 Results 6Neurocrine Biosciences Reports Third Quarter 2009 Results 7Neurocrine Biosciences Reports Third Quarter 2009 Results 8Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast 2
    (Date:5/1/2015)... 2015 It’s raining bills on Capitol Hill ... to expand federal support for telemedicine. , “Such ... been working with Congress,” said Jonathan Linkous, CEO of the ... nation is poised to embrace the use of telecommunications in ... in fulfilling ATA’s mission to improve quality, access, equity and ...
    (Date:5/1/2015)... May 01, 2015 Ernst & Young ... Joshua Rosenthal, Co-Founder & CSO, and Burak Sezen, Co-Founder ... the EY Entrepreneur Of The Year® 2015 Awards ... Young is a global leader in assurance, tax, ... be one of the top audit companies in the ...
    (Date:5/1/2015)... The Quail Creek Relay for Life Team raised over $89,000 ... Creek Relay team has raised almost $860,000. Quail Creek ... their biggest event, January’s Dinner and Auction; an annual Putting ... Relay for Life team was established to honor a member’s ... “I was hooked when I learned how the money raised ...
    (Date:5/1/2015)... As the sale of legal, recreational cannabis ... people in the industry are looking back with some ... annual report by the ArcView Group , the ... reached nearly $3 billion in combined wholesale and retail ... combined with the ongoing economic recovery, has led to ...
    (Date:5/1/2015)... The frozen yogurt chain sweetFrog Enterprises is ... and the Myrtle Beach Pellicans (SC). As part of ... offer fans discounts at local sweetFrog locations. , “We ... Luke Shook, co-owner of the Hickory sweetFrog. “Sponsoring ... forward to enjoying the games and the great taste ...
    Breaking Medicine News(10 mins):Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 3Health News:sweetFrog Announces Minor League Baseball Partnerships 2
    ... strategy to hunt for human viruses described in this ... team who found the cause of Kaposis sarcoma has ... rare but deadly skin cancer called Merkel cell carcinoma. ... researchers, Huichen Feng, Ph.D., Masahiro Shuda, Ph.D., Yuan Chang, ...
    ... better treatments, researchers say , , THURSDAY, Jan. 17 (HealthDay News) ... twins, scientists say they,re gaining new insight into how some ... The researchers report in a new study that both twins ... shared cells that mutated and became precancerous. In one of ...
    ... Bionic Woman use bionic eyes to zoom in on far-off ... or create virtual crosshairs. Off the screen, virtual displays have ... help vision-impaired people, holographic driving control panels and even as ... , The device to make this happen may be familiar. ...
    ... ATLANTA, Jan. 17 Fundraising for two of,Atlanta,s ... Atlanta Mayor Shirley Franklin and Wachovia,s Atlanta ... to the Atlanta BeltLine,Partnership and the Center for ... Foundation. The gifts will go toward each initiative,s,capital ...
    ... FOREST, Ill., Jan. 17 Hospira, Inc.,(NYSE: HSP ... it will host a conference call to discuss its ... Thursday, Feb. 28, 2008,at 8 a.m. Central Time., ... results,earlier that morning, before the U.S. stock market open ...
    ... officials are constantly in battle mode against illness ... to fight these deadly foes they need more ... Researchers from the Regenstrief Institute and the Indiana ... electronic medical laboratory reporting (ELR) improves both the ...
    Cached Medicine News:Health News:Newly discovered virus linked to deadly skin cancer 2Health News:Newly discovered virus linked to deadly skin cancer 3Health News:Newly discovered virus linked to deadly skin cancer 4Health News:Study Gets Closer to Origins of Leukemia 2Health News:Contact lenses with circuits, lights a possible platform for superhuman vision 2Health News:Contact lenses with circuits, lights a possible platform for superhuman vision 3Health News:Wachovia Foundation Announces $1 Million Each for Atlanta BeltLine Partnership, Center for Civil and Human Rights 2Health News:Wachovia Foundation Announces $1 Million Each for Atlanta BeltLine Partnership, Center for Civil and Human Rights 3Health News:Battling potential disease outbreaks online 2
    ... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
    ... 5500TM is the worlds first spot ... and heart rate to use reflectance ... uses SPO Medicals patented technology to ... more usable for many patients and ...
    All-in-One Fingertip Oximeter...
    The reliable and easy-to-use 3900/P pulse oximeter is now more advanced - featuring TruTrak+ technology, the proprietary clinical motion algorithm from Datex+-Ohmeda....
    Medicine Products: